Skip to main content
BNC Korea Co, Ltd logo

BNC Korea Co, Ltd — Investor Relations & Filings

Ticker · 256840 ISIN · KR7256840000 KO Manufacturing
Filings indexed 283 across all filing types
Latest filing 2023-03-17 AGM Information
Country KR South Korea
Listing KO 256840

About BNC Korea Co, Ltd

http://www.bnckorea.co.kr

BNC Korea Co., Ltd. is a biomedical company established in 2007 that engages in the research, development, production, and sale of medical devices, pharmaceuticals, and biologicals. The company specializes in products derived from biomaterials, with a particular focus on hyaluronic acid. Its core product portfolio includes hyaluronic acid-based dermal fillers and botulinum toxin injectables for the medical aesthetics market. BNC Korea operates a GMP-certified facility for manufacturing cutting-edge drug substances and specialty medicines, aiming to develop strategic application products for next-generation bio markets.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Convocation of the Annual General Meeting' (주주총회소집공고) for the 7th Annual General Meeting of Korea BNC Co., Ltd. It includes details such as the meeting date, location, agenda items (financial statement approval, board changes, etc.), and information regarding electronic voting and proxy procedures. This document is a formal notice sent to shareholders to inform them of the upcoming meeting and to solicit their participation/votes. According to the provided definitions, this falls under 'Proxy Solicitation & Information Statement' (PSI) as it provides information and requests votes for the meeting.
2023-03-17 Korean
[기재정정]투자판단관련주요경영사항("보톡스 의약품을 미승인 판매한 6개 제약사 기소" 검찰 보도자료 관련)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from a Korean company (한국비엔씨) regarding a legal matter (indictment by the prosecutor's office). It details a 'major management matter' related to legal proceedings and litigation. Since it specifically addresses legal proceedings and regulatory actions involving the company, it fits the 'Legal Proceedings Report' category.
2023-03-17 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and is a formal filing submitted to the Financial Supervisory Service (FSS) and Korea Exchange (KRX). It contains detailed information regarding the solicitation of proxies for an upcoming Annual General Meeting (AGM), including the purpose of the solicitation, details of the solicitor, and instructions for shareholders to exercise their voting rights. This aligns perfectly with the definition of a Proxy Solicitation & Information Statement (PSI).
2023-03-17 Korean
투자판단관련주요경영사항("보톡스 의약품을 미승인 판매한 6개 제약사 기소" 검찰 보도자료 관련)
Legal Proceedings Report Classification · 100% confidence The document is a formal disclosure regarding legal proceedings (indictment of the company and its employees) related to regulatory issues with the Ministry of Food and Drug Safety. It details the company's response to legal actions and ongoing litigation. This fits the definition of a Legal Proceedings Report (LTR) as it concerns significant legal matters and regulatory actions involving the company.
2023-03-15 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) issued by Korea BNC. It outlines the agenda for the 7th Annual General Meeting, including financial statement approval, board changes, and voting procedures. This document is a standard proxy solicitation material sent to shareholders to inform them of the meeting and request their participation or proxy voting, which fits the definition of a Proxy Solicitation & Information Statement.
2023-03-08 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains detailed information regarding the upcoming Annual General Meeting (AGM) of (주)한국비엔씨, including the date, purpose of the meeting, and instructions for shareholders to exercise their voting rights via proxy or electronic voting. This document is a standard proxy solicitation statement used to request shareholder votes for an upcoming meeting.
2023-03-08 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.